Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lanxi Song

A Chemical and Phosphoproteomic Characterization of Dasatinib Action in Lung Cancer

Nature Chemical Biology

Cell Biology

Molecular Biology

2010

English

Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer

Journal of Thoracic Oncology

English

Related publications

Molecular Mechanism of Action and Potential Biomarkers of Growth Inhibition of Synergistic Combination of Afatinib and Dasatinib Against Gefitinib-Resistant Non-Small Cell Lung Cancer Cells

Oncotarget

Oncology

2018

English

Integrating Proteomic and Phosphoproteomic Data for Pathway Analysis in Breast Cancer

Computer Science Applications

Modeling

2018

English

P2.09-17 a Call to Action: Rapid Collection of Post-Mortem Lung Cancer Tissue in the Community to Enable Lung Cancer Research

Journal of Thoracic Oncology

English

Experimental Lung Cancer in Rabbits Induced by Chemical Carcinogens

Japanese Journal of Lung Cancer

English

Detection and Characterization of Circulating Tumor Cells in Lung Cancer: Why and How?

English

P1.01-47 Phase I/Ii Trial of Dasatinib and Osimertinib in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

Joint Action of Smoking and Asbestos Exposure on Lung Cancer * Author's Reply

Occupational and Environmental Medicine

English

Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells

Molecular and Cellular Proteomics

English

P3.07-09 Characterization of the Nutritional Status in Lung Cancer Patients: A Retrospective Study

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lanxi Song

A Chemical and Phosphoproteomic Characterization of Dasatinib Action in Lung Cancer

Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer

Related publications

Molecular Mechanism of Action and Potential Biomarkers of Growth Inhibition of Synergistic Combination of Afatinib and Dasatinib Against Gefitinib-Resistant Non-Small Cell Lung Cancer Cells

Integrating Proteomic and Phosphoproteomic Data for Pathway Analysis in Breast Cancer

P2.09-17 a Call to Action: Rapid Collection of Post-Mortem Lung Cancer Tissue in the Community to Enable Lung Cancer Research

Experimental Lung Cancer in Rabbits Induced by Chemical Carcinogens

Detection and Characterization of Circulating Tumor Cells in Lung Cancer: Why and How?

P1.01-47 Phase I/Ii Trial of Dasatinib and Osimertinib in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Joint Action of Smoking and Asbestos Exposure on Lung Cancer * Author's Reply

Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells

P3.07-09 Characterization of the Nutritional Status in Lung Cancer Patients: A Retrospective Study